Planning for failure makes better business sense, as long as it cheap and quick
Biotech companies involved in drug development should plan for failure, rather than success, says Dr Wilding, of Ian Wilding Associates.
Biotech companies involved in drug development should plan for failure, rather than success, says Dr Wilding, of Ian Wilding Associates.
Other
Oct 31, 2006
0
0
Scientists from the Leibniz-Institute for Zoo and Wildlife Research (IZW) in Berlin, Germany, together with veterinarians from Australia, have performed a world first by harvesting egg cells from a black rhino for the purpose ...
Oct 31, 2006
0
0
What does a colorful and noisy backyard insect have to do with nanotechnology? Plenty, according to Jin Zhang and Zhongfan Liu, both professors at Peking University.
Nanophysics
Oct 31, 2006
0
0
Shuttle astronauts will make one final house call to NASA's Hubble Space Telescope as part of a mission to extend and improve the observatory's capabilities through 2013. NASA Administrator Michael Griffin announced plans ...
Space Exploration
Oct 31, 2006
0
0
For forty years supersolid behavior has been predicted, and since the 1970s, theories about supersolid behavior involving helium-4 have been developed. However, it wasn’t until 2004 that some evidence of supersolid behavior ...
Researchers at the University of Warwick are examining a way of using bacteria to manufacture a new suite of potential anti-cancer drugs that are difficult to create synthetically on a lab bench.
Oct 31, 2006
0
0
In the latest issue of PNAS, Proceedings of the National Academy of Sciences, a Swedish-American team of researchers show how selective gene amplification-mass copying of a specific gene-can increase the speed with which ...
Oct 31, 2006
0
0